intui advised Scilife shareholders on the growth equity investment by Five Elms Capital. Scilife developed QMS – an innovative tool that enables players in the life sciences sector to optimise their quality management.
The transaction involved the transfer of Scilife’s shares to Five Elms Capital, with shareholders partially rolling over into Five Elms Capital. This investment will allow Scilife to strengthen its market presence and the adoption of its innovative QMS.
We wish Filip Heitbrink, founder and CEO of Scilife, and his team every success with this great next step for Scilife.
Intui’s team included Anneleen Steeno, Matthias Jans and Philippe Van Lierde.
Congratulations to all parties involved!
See press release: https://www.scilife.io/press-releases/scilife-five-elms-capital-partnership